New Publication from Vizeacoumar Lab in Sci Rep

"The EphB6 receptor is overexpressed in pediatric T cell acute lymphoblastic leukemia and increases its sensitivity to doxorubicin treatment"

"The EphB6 receptor is overexpressed in pediatric T cell acute lymphoblastic leukemia and increases its sensitivity to doxorubicin treatment"


Authors: El Zawily A, McEwen E, Toosi B, Vizeacoumar FS, Freywald T, Vizeacoumar FJ*, Freywald A*.

Sci Rep. 2017 Nov 7;7(1):14767. doi: 10.1038/s41598-017-15200-3. PMID: 29116180; * co-corresponding authors


 The paper can be accessed here: https://www.ncbi.nlm.nih.gov/pubmed/29116180
Share this story